A new study suggests that the shingles vaccine may help prevent dementia by reducing the risk of varicella-zoster virus ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
Alerts have been issued about the rising number of chickenpox cases in Northern New South Wales this year. Meanwhile, ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...
NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
The vaccine was also found to lower the risk of blood clots, heart attack and stroke, and death VACCINES are the most effective way to prevent many infectious diseases. Some jabs may even protect ...
A large, new study tracked older adults who had received the shingles vaccination and received promising results. The scientists report that those who received a shingles vaccine shot were at a ...
Following AIS or TIA, a fifth of patients have varicella-zoster virus reactivation in cerebrospinal fluid. A fifth of patients have varicella-zoster virus (VZV) reactivation in cerebrospinal fluid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback